Africa Health Research Institute, Durban, South Africa.
HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
BMC Med. 2020 Mar 25;18(1):81. doi: 10.1186/s12916-020-01529-6.
Immunological damage in acute HIV infection (AHI) may predispose to detrimental clinical sequela. However, studies on the earliest HIV-induced immunological changes are limited, particularly in sub-Saharan Africa. We assessed the plasma cytokines kinetics, and their associations with virological and immunological parameters, in a well-characterized AHI cohort where participants were diagnosed before peak viremia.
Blood cytokine levels were measured using Luminex and ELISA assays pre-infection, during the hyperacute infection phase (before or at peak viremia, 1-11 days after the first detection of viremia), after peak viremia (24-32 days), and during the early chronic phase (77-263 days). Gag-protease-driven replicative capacities of the transmitted/founder viruses were determined using a green fluorescent reporter T cell assay. Complete blood counts were determined before and immediately following AHI detection before ART initiation.
Untreated AHI was associated with a cytokine storm of 12 out of the 33 cytokines analyzed. Initiation of ART during Fiebig stages I-II abrogated the cytokine storm. In untreated AHI, virus replicative capacity correlated positively with IP-10 (rho = 0.84, P < 0.001) and IFN-alpha (rho = 0.59, P = 0.045) and inversely with nadir CD4 T cell counts (rho = - 0.58, P = 0.048). Hyperacute HIV infection before the initiation of ART was associated with a transient increase in monocytes (P < 0.001), decreased lymphocytes (P = 0.011) and eosinophils (P = 0.003) at Fiebig stages I-II, and decreased eosinophils (P < 0.001) and basophils (P = 0.007) at Fiebig stages III-V. Levels of CXCL13 during the untreated hyperacute phase correlated inversely with blood eosinophils (rho = - 0.89, P < 0.001), basophils (rho = - 0.87, P = 0.001) and lymphocytes (rho = - 0.81, P = 0.005), suggesting their trafficking into tissues. In early treated individuals, time to viral load suppression correlated positively with plasma CXCL13 at the early chronic phase (rho = 0.83, P = 0.042).
While commencement of ART during Fiebig stages I-II of AHI abrogated the HIV-induced cytokine storm, significant depletions of eosinophils, basophils, and lymphocytes, as well as transient expansions of monocytes, were still observed in these individuals in the hyperacute phase before the initiation of ART, suggesting that even ART initiated during the onset of viremia does not abrogate all HIV-induced immune changes.
急性 HIV 感染(AHI)中的免疫损伤可能使患者易发生有害的临床后果。然而,关于 HIV 早期诱导的免疫变化的研究是有限的,特别是在撒哈拉以南非洲。我们评估了在感染前确诊的特征明确的 AHI 队列中血浆细胞因子的动力学及其与病毒学和免疫学参数的相关性,其中参与者在峰值病毒血症之前发生了感染。
在感染前、超急性感染阶段(在病毒血症首次检测到之前或达到峰值时,即 1-11 天)、峰值病毒血症后(24-32 天)和早期慢性阶段(77-263 天)使用 Luminex 和 ELISA 检测分析测定血液细胞因子水平。使用绿色荧光报告 T 细胞测定法测定传播/原始病毒的 Gag-蛋白酶驱动的复制能力。在开始 ART 之前,在开始治疗前和开始 AHI 检测后立即进行全血细胞计数。
未经治疗的 AHI 与分析的 33 种细胞因子中的 12 种细胞因子风暴有关。在 Fiebig 阶段 I-II 期间开始 ART 可消除细胞因子风暴。在未经治疗的 AHI 中,病毒复制能力与 IP-10(rho = 0.84,P < 0.001)和 IFN-α(rho = 0.59,P = 0.045)呈正相关,与 CD4 细胞计数的最低值(rho = -0.58,P = 0.048)呈负相关。在开始 ART 之前的超急性 HIV 感染与 Fiebig 阶段 I-II 时单核细胞的短暂增加(P < 0.001)、淋巴细胞(P = 0.011)和嗜酸性粒细胞(P = 0.003)减少以及 Fiebig 阶段 III-V 时嗜酸性粒细胞(P < 0.001)和嗜碱性粒细胞(P = 0.007)减少有关。未经治疗的超急性阶段 CXCL13 水平与血液嗜酸性粒细胞(rho = -0.89,P < 0.001)、嗜碱性粒细胞(rho = -0.87,P = 0.001)和淋巴细胞(rho = -0.81,P = 0.005)呈负相关,表明它们向组织转移。在早期接受治疗的个体中,病毒载量抑制的时间与早期慢性阶段的血浆 CXCL13 呈正相关(rho = 0.83,P = 0.042)。
虽然在 AHI 的 Fiebig 阶段 I-II 期间开始 ART 可消除 HIV 诱导的细胞因子风暴,但在开始 ART 之前的超急性阶段仍观察到嗜酸性粒细胞、嗜碱性粒细胞和淋巴细胞的大量减少以及单核细胞的短暂增加,表明即使在病毒血症发作时开始 ART 也不能消除所有 HIV 诱导的免疫变化。